Cargando...
Plasma Rich in Growth Factors for the Treatment of Cicatrizing Conjunctivitis
PURPOSE: The objective was to evaluate the clinical results obtained from the use of immunosafe plasma rich in growth factors (isPRGF) in the treatment of patients with cicatrizing conjunctivitis (CC) who had not responded to the usual therapy. PATIENTS AND METHODS: This is a retrospective study tha...
Gardado en:
| Publicado en: | Clin Ophthalmol |
|---|---|
| Main Authors: | , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
Dove
2020
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7306461/ https://ncbi.nlm.nih.gov/pubmed/32606577 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/OPTH.S252253 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|